InvestorsHub Logo
Followers 8
Posts 628
Boards Moderated 0
Alias Born 05/26/2021

Re: shoondale post# 11586

Friday, 12/03/2021 9:49:47 AM

Friday, December 03, 2021 9:49:47 AM

Post# of 13742
I disagree.. firstly the muscle rub was created as vessel to show proof of concept, which they did successfully, then ibuprofen test to show that it works with medicine, now the data and test are completed things are moving forward.. they have a decades of research that have culminated to the precipice we are on right now … if your invested in qnta it’s the big picture one should look at - and muscle rub sales is not the epitome of the big picture. In order to garner license deals in regards to medicine there are many hoops to jump through … if you go back and trad through data and relisten to cc calls you’ll hear that muscle rub was chosen in big part because they could quietly bring it to market for proof of concept to then utilize as the data / tool to the approach drug companies… the muscle rub while yes a product that is a revenue stream - was never intended as their sole money maker .. the scorpion ranch has been expanded and will continue to grow .. the Dominican Republic has added escozine to their covid protocol, the deal with Mexico is a go and the escozine CAN now be exported from the DR direct to Mexico.
The fda process is ongoing and in forward motion …. The entire business world is moving slower because of covid - however, ironically in the case of qnta covid is actually helping propel escozine to market sooner … which will subsequently help fast track it now for cancer use and more .. much is culminating currently

I’m long here … and holding $cience
IMO QNTA has the science and direction we as planet need right now .. the last cc the Doctor discussed a different approach to covid vaccines .. that alone is huge
GLTA

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.